IRCT20090117001556N146
Recruiting
Phase 2
Sulforaphane as an adjuvant therapy in children with attention-deficit/hyperactivity disorder (ADHD): A randomized, double-blind, placebo-controlled clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 6\-11 years
- •Diagnosis of ADHD based on DSM5
Exclusion Criteria
- •Age range outside 6\-11 years
- •Diagnosis of a serious disease, or disease requiring surgery, or neurological diseases
- •Diagnosis of a psychiatric disorder and taking neuropsychiatric drugs, except for ADD
- •History of treatment with sulforaphane in the last three months
- •History of treatment with neuroleptic medication in the last six months
- •Weight less than 13\.5 kg
- •Mental retardation
- •A systolic blood pressure greater than 125 or a resting heart rate less than 60 or greater than 115
- •History of allergy to sulforaphane or methylphenidate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 2
Magnesium sulfate as an adjuvant therapy in neonatal hypoxianeonatal hypoxiahypoxic ischemic encephalopathy S100-b magnesium sulfate neonatesTCTR20180720002Tanta university hospital60
Completed
Phase 3
A clinical trial to study the effect of adding magnesium sulphate (IV) in children not responding to conventional treatment of bronchiolitis.Health Condition 1: null- BronchiolitisCTRI/2013/04/003556Deptt of Pediatrics Lady Hardinge Medical College78
Recruiting
Phase 2
The effect of Sulforaphane on the treatment of mild to moderate depression in post percutaneous coronary intervention patientsDepression.Major depressive disorder, single episode, moderateF32.1IRCT20090117001556N128Tehran University of Medical Sciences50
Active, not recruiting
Phase 1
Safety and feasibility of xenon as an adjuvant to sevoflurane anesthesia, to children who are undergoing an interventional or diagnostic cardiac catheterization: a randomized controlled clinical trialXenon anesthesia in children undergoing cardiac catheterizationTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2014-002510-23-BEniversity hospitals of Leuven40
Recruiting
Phase 2
The effect of sulforaphane on depression in women with PCOSSeverity of depression.Polycystic ovarian syndromeE28.2IRCT20090117001556N144Tehran University of Medical Sciences50